Pharmaceutical Online Videos
-
Curia Capabilities Update May 2026: HPAPI & API Development
5/28/2026
What is critical when choosing a CDMO as a partner for HPAPI development and manufacturing? Curia's Brian Haney breaks down the key questions, controls, and expertise every innovator should evaluate.
-
Ardena Capabilities Update May 2026: HPAPI & API Development
5/28/2026
Learn how integrated, science-led CDMO/CRO strategies can manage the full complexity of high-potent drug development — from containment-focused manufacturing and ultra-sensitive analytics to product delivery.
-
Novartis Capabilities Update May 2026: Mammalian Cell Culture
5/28/2026
Explore a global contract manufacturing network with proven regulatory success, flexible partnership models, and end-to-end capabilities spanning biologics, advanced therapies, and fill-finish to support your program.
-
KBI Biopharma Capabilities Update May 2026: Mammalian Cell Culture
5/28/2026
Uncover how advanced cell line development platforms, targeted integration technologies, and data-driven selection tools can accelerate biologics development from DNA to patient with greater speed, stability, and confidence.
-
AGC Biologics Capabilities Update May 2026: Mammalian Cell Culture
5/28/2026
See how flexible single-use manufacturing strategies can accelerate scale-up, improve efficiency, and help streamline the journey from clinical development to commercialization.
-
Samsung Biologics Capabilities Update May 2026: Large Molecule
5/28/2026
Watch this on-demand session to explore the future of global biologics manufacturing, dual-sourcing strategies, and next-generation expansion plans in advanced therapies.
-
Rezon Bio Capabilities Update May 2026: Large Molecule
5/28/2026
Discover how tailored biologics development strategies can improve scalability, reduce tech transfer risk, and create more reliable pathways from early development to commercial supply.
-
Alcami Capabilities Update May 2026: Large Molecule
5/28/2026
Watch this on-demand session to learn risk-based strategies for optimizing biologic drug substance-to-product transitions while minimizing aggregation and process stress.
-
Leadership Perspectives From The Grand Opening of Flamma's Honkai 2 Facility
5/22/2026
A two-day celebration in Dalian highlighted a major global investment milestone, featuring leadership perspectives, opening ceremonies, and the strategic vision behind expanded cGMP manufacturing capabilities.
-
Advance Traditional CCIT With Dynamic Vacuum Decay
5/22/2026
Dynamic vacuum decay advances traditional CCIT by improving leak detection. Learn how controlled, variable vacuum conditions deliver greater sensitivity and more reliable insight into package integrity.